Fri, November 18, 2022
Thu, November 17, 2022
Wed, November 16, 2022
Tue, November 15, 2022
Mon, November 14, 2022

Graig Suvannavejh Maintained (BTAI) at Strong Buy with Decreased Target to $18 on, Nov 16th, 2022

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-18-on-nov-16th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication
Graig Suvannavejh of Mizuho, Maintained "BioXcel Therapeutics, Inc." (BTAI) at Strong Buy with Decreased Target from $19 to $18 on, Nov 16th, 2022.

Graig has made no other calls on BTAI in the last 4 months.



There are 3 other peers that have a rating on BTAI. Out of the 3 peers that are also analyzing BTAI, 0 agree with Graig's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Graig


  • Sumant Kulkarni of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $76 on, Friday, November 11th, 2022
  • Yatin Suneja of "Guggenheim" Maintained at Strong Buy with Decreased Target to $25 on, Friday, November 11th, 2022
  • Raghuram Selvaraju of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $85 on, Wednesday, August 24th, 2022